Updates are available Correction dated 2024-09-07
Click to view Correction: https://doi.org/10.1038/s41537-024-00500-1
-
Authors
Kristensen, Tina D. http://orcid.org/0000-0001-9616-762X
Ambrosen, Karen S. http://orcid.org/0000-0002-5638-2357
Raghava, Jayachandra M.
Syeda, Warda T. http://orcid.org/0000-0001-6294-622X
Dhollander, Thijs
Lemvigh, Cecilie K. http://orcid.org/0000-0002-3647-9709
Bojesen, Kirsten B.
Barber, Anita D.
Nielsen, Mette Ø.
Rostrup, Egill
Pantelis, Christos http://orcid.org/0000-0002-9565-0238
Fagerlund, Birgitte http://orcid.org/0000-0003-4547-2944
Glenthøj, Birte Y. http://orcid.org/0000-0003-3056-7262
Ebdrup, Bjørn H.
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 23 July 2024
First Online: 31 August 2024
Change Date: 7 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41537-024-00500-1
Competing interests
: B.H.E. is part of the Advisory Board of Eli Lilly Denmark A/S, Janssen-Cilag, Lundbeck Pharma A/S, and Takeda Pharmaceutical Company Ltd; and has received lecture fees from Bristol-Myers Squibb, Otsuka Pharma Scandinavia AB, Eli Lilly Company, and Lundbeck Pharma A/S. K.B.B. received lecture fees from Lundbeck Pharma A/S.
